Business
Medically Minded, Inc. (OTC Pink: MMHC) to Launch New Product Line
Medically Minded, Inc. (OTC Pink: MMHC) to Launch New Product Line.

About this update from Sixty Six Oilfield Services, Inc.
[{"type":"text","content":"\n \n \n Medically Minded, Inc. (OTC Pink: MMHC) to Launch New Product Line\n \n \nMedically Minded, Inc. (OTC Pink: MMHC) to Launch New Product Line\n \n ST. THOMAS, U.S. VIRGIN ISLANDS--(Marketwired - Mar 16, 2016) -  Medically Minded, Inc. (OTC PINK: MMHC), announced that it will begin marketing and distributing end consumer products containing the hemp plant extract or Cannabidiol (\"CBD\") under the \"Medically Minded\" brand name. These products will include 100% CBD-Rich Hemp Oil in a variety of sizes and flavors.\n CBD Rich Hemp Oil is an oil extracted from Industrial Hemp plants (stalks and seeds) with a High Grade of Cannabidiol (CBD). The plants used are specifically and uniquely bred to comprise high concentrations of the naturally occurring Cannabinoid Cannabidiol (CBD). Cannabidiol oil that comes from industrial hemp plants, such as will be the case with our products, are considered by the FDA to be a dietary supplement (not a medication) since they are made from industrial hemp plants.\n If you live in the US, this means you don't need a prescription and can legally purchase and consume Cannabidiol in any state. Cannabidiol from industrial hemp also has the added benefit of having virtually no THC. This is why it's not possible to get \"high\" with these products. There simply isn't enough THC.\n The Company is currently completing initial discussions with a manufacturer and supplier of quality, high-grade CBD rich hemp oil to supply the products for our initial territorial launches. The Company expects to announce an initial Memorandum of Understanding for a supplier/distribution relationship shortly.\n Stephen Jones, CEO of Medically Minded, stated, \"While we continue our push for a medical marijuana space in the U.S. Virgin Islands, we felt it was important to expand into other areas of the Cannabidiol industry that could provide beneficial products to the market and immediate revenues to the Company and its shareholders.\"\n Jones continued, \"After extensive research into the industrial hemp-CBD market, we concluded that there is a growing demand and need for CBD-enriched products. Current studies have also shown an interest and basis for further trials for CBD in the areas of pain, epilepsy, and brain diseases to name a few.\"\n Medically Minded is excited about the opportunity to enter the revenue gen...